US Stock MarketDetailed Quotes

United Therapeutics (UTHR)

Watchlist
  • 575.290
  • -4.250-0.73%
Trading May 14 14:36 ET
24.42BMarket Cap21.27P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

United Therapeutics (UTHR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
-1.62%781.5M
10.61%3.18B
7.38%790.2M
6.76%799.5M
11.71%798.6M
17.22%794.4M
23.63%2.88B
19.72%735.9M
22.89%748.9M
19.85%714.9M
Operating revenue
-1.67%776.2M
10.61%3.18B
7.32%807.6M
6.62%792.6M
11.70%793.1M
16.48%789.4M
23.63%2.88B
22.42%752.5M
21.99%743.4M
19.03%710M
Cost of revenue
44.22%133.4M
24.12%384.4M
36.23%103.4M
21.42%100.9M
12.60%87.6M
26.89%92.5M
20.27%309.7M
6.90%75.9M
18.54%83.1M
21.37%77.8M
Gross profit
-7.66%648.1M
8.98%2.8B
4.06%686.8M
4.93%698.6M
11.60%711M
16.05%701.9M
24.04%2.57B
21.39%660M
23.46%665.8M
19.67%637.1M
Operating expense
1.00%322.3M
14.42%1.28B
11.14%329.3M
20.07%309.3M
2.40%324.8M
28.41%319.1M
26.49%1.12B
4.48%296.3M
21.34%257.6M
44.84%317.2M
Selling and administrative expenses
8.23%184.1M
14.48%731.1M
16.80%189.8M
17.98%181.8M
7.43%190.8M
17.80%170.1M
33.85%638.6M
22.92%162.5M
20.77%154.1M
36.62%177.6M
-Selling and marketing expense
7.89%28.7M
23.16%118.6M
21.11%32.7M
36.71%28.3M
22.05%31M
14.66%26.6M
17.73%96.3M
12.03%27M
0.00%20.7M
26.37%25.4M
-General and administrative expense
8.29%155.4M
12.94%612.5M
15.94%157.1M
15.07%153.5M
4.99%159.8M
18.40%143.5M
37.19%542.3M
25.35%135.5M
24.79%133.4M
38.49%152.2M
Research and development costs
-7.25%138.2M
14.35%550M
4.26%139.5M
23.19%127.5M
-4.01%134M
43.13%149M
17.89%481M
-11.62%133.8M
22.20%103.5M
56.85%139.6M
Operating profit
-14.89%325.8M
4.77%1.52B
-1.70%357.5M
-4.63%389.3M
20.73%386.2M
7.44%382.8M
22.21%1.45B
39.83%363.7M
24.83%408.2M
2.07%319.9M
Net non-operating interest income expense
-13.78%38.8M
10.44%172.5M
-3.14%40.1M
9.32%43.4M
27.17%44M
11.11%45M
51.06%156.2M
15.32%41.4M
33.67%39.7M
54.46%34.6M
Non-operating interest income
-18.20%41.8M
-3.57%192M
-12.37%43.2M
-6.83%46.4M
11.04%51.3M
-5.02%51.1M
22.37%199.1M
-3.33%49.3M
9.93%49.8M
24.19%46.2M
Non-operating interest expense
-50.82%3M
-54.55%19.5M
-60.76%3.1M
-70.30%3M
-37.07%7.3M
-54.14%6.1M
-27.66%42.9M
-47.68%7.9M
-35.26%10.1M
-21.62%11.6M
Other net income (expense)
-976.74%-46.3M
137.06%24.2M
639.53%46.4M
108.94%5.3M
-2,825.00%-21.8M
-338.89%-4.3M
-366.43%-65.3M
-1,333.33%-8.6M
-1,110.20%-59.3M
233.33%800K
Special income (charges)
----
65.26%-24.7M
86.67%-800K
98.77%-800K
---21.7M
----
---71.1M
---6M
---65.1M
--0
-Less:Impairment of capital assets
----
--21.7M
--0
--0
--21.7M
----
--0
--0
--0
--0
-Less:Other special charges
----
-95.78%3M
-86.67%800K
-98.77%800K
----
----
--71.1M
--6M
--65.1M
----
-Write off
----
----
----
----
----
----
--0
----
----
----
Other non- operating income (expenses)
-976.74%-46.3M
743.10%48.9M
1,915.38%47.2M
5.17%6.1M
-112.50%-100K
-338.89%-4.3M
141.43%5.8M
-333.33%-2.6M
218.37%5.8M
233.33%800K
Income before tax
-24.84%318.3M
11.36%1.71B
11.98%444M
12.71%438M
14.95%408.4M
6.25%423.5M
20.77%1.54B
34.22%396.5M
10.46%388.6M
6.00%355.3M
Income tax
-57.16%43.4M
10.26%379.2M
-16.28%79.7M
24.91%99.3M
28.11%98.9M
10.11%101.3M
18.79%343.9M
21.58%95.2M
-5.58%79.5M
1.58%77.2M
Net income
-14.68%274.9M
11.68%1.33B
20.91%364.3M
9.58%338.7M
11.29%309.5M
5.09%322.2M
21.35%1.2B
38.78%301.3M
15.51%309.1M
7.29%278.1M
Net income continuous Operations
-14.68%274.9M
11.68%1.33B
20.91%364.3M
9.58%338.7M
11.29%309.5M
5.09%322.2M
21.35%1.2B
38.78%301.3M
15.51%309.1M
7.29%278.1M
Minority interest income
Net income attributable to the parent company
-14.68%274.9M
11.68%1.33B
20.91%364.3M
9.58%338.7M
11.29%309.5M
5.09%322.2M
21.35%1.2B
38.78%301.3M
15.51%309.1M
7.29%278.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-14.68%274.9M
11.68%1.33B
20.91%364.3M
9.58%338.7M
11.29%309.5M
5.09%322.2M
21.35%1.2B
38.78%301.3M
15.51%309.1M
7.29%278.1M
Basic earnings per share
-11.98%6.32
13.96%30.13
24.78%8.41
11.54%7.73
9.58%6.86
10.12%7.18
25.67%26.44
45.89%6.74
21.37%6.93
13.20%6.26
Diluted earnings per share
-12.22%5.82
13.07%27.86
24.39%7.7
12.05%7.16
9.57%6.41
7.46%6.63
24.38%24.64
41.97%6.19
18.77%6.39
11.64%5.85
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue -1.62%781.5M10.61%3.18B7.38%790.2M6.76%799.5M11.71%798.6M17.22%794.4M23.63%2.88B19.72%735.9M22.89%748.9M19.85%714.9M
Operating revenue -1.67%776.2M10.61%3.18B7.32%807.6M6.62%792.6M11.70%793.1M16.48%789.4M23.63%2.88B22.42%752.5M21.99%743.4M19.03%710M
Cost of revenue 44.22%133.4M24.12%384.4M36.23%103.4M21.42%100.9M12.60%87.6M26.89%92.5M20.27%309.7M6.90%75.9M18.54%83.1M21.37%77.8M
Gross profit -7.66%648.1M8.98%2.8B4.06%686.8M4.93%698.6M11.60%711M16.05%701.9M24.04%2.57B21.39%660M23.46%665.8M19.67%637.1M
Operating expense 1.00%322.3M14.42%1.28B11.14%329.3M20.07%309.3M2.40%324.8M28.41%319.1M26.49%1.12B4.48%296.3M21.34%257.6M44.84%317.2M
Selling and administrative expenses 8.23%184.1M14.48%731.1M16.80%189.8M17.98%181.8M7.43%190.8M17.80%170.1M33.85%638.6M22.92%162.5M20.77%154.1M36.62%177.6M
-Selling and marketing expense 7.89%28.7M23.16%118.6M21.11%32.7M36.71%28.3M22.05%31M14.66%26.6M17.73%96.3M12.03%27M0.00%20.7M26.37%25.4M
-General and administrative expense 8.29%155.4M12.94%612.5M15.94%157.1M15.07%153.5M4.99%159.8M18.40%143.5M37.19%542.3M25.35%135.5M24.79%133.4M38.49%152.2M
Research and development costs -7.25%138.2M14.35%550M4.26%139.5M23.19%127.5M-4.01%134M43.13%149M17.89%481M-11.62%133.8M22.20%103.5M56.85%139.6M
Operating profit -14.89%325.8M4.77%1.52B-1.70%357.5M-4.63%389.3M20.73%386.2M7.44%382.8M22.21%1.45B39.83%363.7M24.83%408.2M2.07%319.9M
Net non-operating interest income expense -13.78%38.8M10.44%172.5M-3.14%40.1M9.32%43.4M27.17%44M11.11%45M51.06%156.2M15.32%41.4M33.67%39.7M54.46%34.6M
Non-operating interest income -18.20%41.8M-3.57%192M-12.37%43.2M-6.83%46.4M11.04%51.3M-5.02%51.1M22.37%199.1M-3.33%49.3M9.93%49.8M24.19%46.2M
Non-operating interest expense -50.82%3M-54.55%19.5M-60.76%3.1M-70.30%3M-37.07%7.3M-54.14%6.1M-27.66%42.9M-47.68%7.9M-35.26%10.1M-21.62%11.6M
Other net income (expense) -976.74%-46.3M137.06%24.2M639.53%46.4M108.94%5.3M-2,825.00%-21.8M-338.89%-4.3M-366.43%-65.3M-1,333.33%-8.6M-1,110.20%-59.3M233.33%800K
Special income (charges) ----65.26%-24.7M86.67%-800K98.77%-800K---21.7M-------71.1M---6M---65.1M--0
-Less:Impairment of capital assets ------21.7M--0--0--21.7M------0--0--0--0
-Less:Other special charges -----95.78%3M-86.67%800K-98.77%800K----------71.1M--6M--65.1M----
-Write off --------------------------0------------
Other non- operating income (expenses) -976.74%-46.3M743.10%48.9M1,915.38%47.2M5.17%6.1M-112.50%-100K-338.89%-4.3M141.43%5.8M-333.33%-2.6M218.37%5.8M233.33%800K
Income before tax -24.84%318.3M11.36%1.71B11.98%444M12.71%438M14.95%408.4M6.25%423.5M20.77%1.54B34.22%396.5M10.46%388.6M6.00%355.3M
Income tax -57.16%43.4M10.26%379.2M-16.28%79.7M24.91%99.3M28.11%98.9M10.11%101.3M18.79%343.9M21.58%95.2M-5.58%79.5M1.58%77.2M
Net income -14.68%274.9M11.68%1.33B20.91%364.3M9.58%338.7M11.29%309.5M5.09%322.2M21.35%1.2B38.78%301.3M15.51%309.1M7.29%278.1M
Net income continuous Operations -14.68%274.9M11.68%1.33B20.91%364.3M9.58%338.7M11.29%309.5M5.09%322.2M21.35%1.2B38.78%301.3M15.51%309.1M7.29%278.1M
Minority interest income
Net income attributable to the parent company -14.68%274.9M11.68%1.33B20.91%364.3M9.58%338.7M11.29%309.5M5.09%322.2M21.35%1.2B38.78%301.3M15.51%309.1M7.29%278.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -14.68%274.9M11.68%1.33B20.91%364.3M9.58%338.7M11.29%309.5M5.09%322.2M21.35%1.2B38.78%301.3M15.51%309.1M7.29%278.1M
Basic earnings per share -11.98%6.3213.96%30.1324.78%8.4111.54%7.739.58%6.8610.12%7.1825.67%26.4445.89%6.7421.37%6.9313.20%6.26
Diluted earnings per share -12.22%5.8213.07%27.8624.39%7.712.05%7.169.57%6.417.46%6.6324.38%24.6441.97%6.1918.77%6.3911.64%5.85
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.31%
Sample Name
Sample Code
 +14.60%
Sample Name
Sample Code
 +13.91%
4
United States Oil Fund LP
USO
+12.98%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+10.40%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +13.36%
Sample Name
Sample Code
 +9.35%
Sample Name
Sample Code
 +9.12%
4
Hesai
HSAI
+7.75%
5
NIO Inc
NIO
+7.41%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -